NTI drug but with high CV [Power / Sample Size]

posted by Mikalai  – Belarus, 2019-12-14 15:39  – Posting: # 20975
Views: 1,014

Dear all.
What would be a sample size for a BE study when the CV of the drug is 30% but bioequivalence should be in range 90_110%? Our assumption is around 400 subject if the design is standard, and 200 if the design is replicative
Best regards.

Complete thread:

Activity
 Admin contact
20,635 posts in 4,324 threads, 1,434 registered users;
online 5 (0 registered, 5 guests [including 2 identified bots]).
Forum time: 11:50 CEST (Europe/Vienna)

Facts do not cease to exist because they are ignored.    Aldous Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5